Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
51.10
-1.58 (-3.00%)
At close: Apr 28, 2026, 4:00 PM EDT
51.15
+0.05 (0.10%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Tempus AI Employees
Tempus AI had 3,800 employees as of December 31, 2025. The number of employees increased by 1,400 or 58.33% compared to the previous year.
Employees
3,800
Change (1Y)
1,400
Growth (1Y)
58.33%
Revenue / Employee
$334,681
Profits / Employee
-$64,481
Market Cap
9.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3,800 | 1,400 | 58.33% |
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Teladoc Health | 5,600 |
| Omnicell | 3,580 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| 10x Genomics | 1,178 |
TEM News
- 12 hours ago - Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - Business Wire
- 5 days ago - Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine - Business Wire
- 7 days ago - Tempus to Report First Quarter 2026 Financial Results on May 5 - Business Wire
- 13 days ago - Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring - Business Wire
- 14 days ago - Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz - Benzinga
- 14 days ago - Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 14 days ago - Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026 - Business Wire
- 15 days ago - Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care - Business Wire